dASK1-VHL is an orally active PROTAC degrader targeting ASK1. It effectively binds to VHL, promoting the selective degradation of ASK1. By reducing ASK1 protein levels, dASK1-VHL inhibits the activation of p38 MAPK and decreases liver lipid content, offering new insights for MASH research.
Target:
p38 MAPK|||PROTACs|||ASK
* VAT and and shipping costs not included. Errors and price changes excepted
